2-(4-Hydroxyphenyl)quinazolin-4(3H)-one

Name: 2-(4-Hydroxyphenyl)quinazolin-4(3H)-one | 89860-51-5
Brand: US-CATO
SKU: S57C1579989_20_MG
Price: 19998.0 USD
Availability: InStock

Cat. No S57C1579989_20_MG

Vendor: US-CATO

Product Information

Product Name

2-(4-Hydroxyphenyl)quinazolin-4(3H)-one

Brand Name

US-CATO

Product Number

C1579989

CAS

89860-51-5

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

135405744

IUPAC Name

2-(4-hydroxyphenyl)-3H-quinazolin-4-one

InChI Key

HMZVOPJPTNTGGO-UHFFFAOYSA-N

SMILES

C1=CC=C2C(=C1)C(=O)NC(=N2)C3=CC=C(C=C3)O

References Data Source From Pubchem

Therapeutic significance of β-glucuronidase activity and its inhibitors: A review

Publication Name: European Journal of Medicinal Chemistry

Publication Date: 2020-02-01

DOI: 10.1016/j.ejmech.2019.111921

Cink4T, a quinazolinone-based dual inhibitor of Cdk4 and tubulin polymerization, identified via ligand-based virtual screening, for efficient anticancer therapy

Publication Name: European Journal of Medicinal Chemistry

Publication Date: 2019-03-01

DOI: 10.1016/j.ejmech.2019.01.011

Synthesis and structure–activity relationship study of novel quinazolinone-based inhibitors of MurA

Publication Name: Bioorganic & Medicinal Chemistry Letters

Publication Date: 2017-08-01

DOI: 10.1016/j.bmcl.2017.05.064

Quinazoline derivatives as selective CYP1B1 inhibitors

Publication Name: European Journal of Medicinal Chemistry

Publication Date: 2017-04-21

DOI: 10.1016/j.ejmech.2017.02.032

Structure-activity relationships of 2-arylquinazolin-4-ones as highly selective and potent inhibitors of the tankyrases

Publication Name: European Journal of Medicinal Chemistry

Publication Date: 2016-08-08

DOI: 10.1016/j.ejmech.2016.04.041

2-(4-Hydroxyphenyl)quinazolin-4(3H)-one

Product Information

General Information

References Data Source From Pubchem

Therapeutic significance of β-glucuronidase activity and its inhibitors: A review

Cink4T, a quinazolinone-based dual inhibitor of Cdk4 and tubulin polymerization, identified via ligand-based virtual screening, for efficient anticancer therapy

Synthesis and structure–activity relationship study of novel quinazolinone-based inhibitors of MurA

Quinazoline derivatives as selective CYP1B1 inhibitors

Structure-activity relationships of 2-arylquinazolin-4-ones as highly selective and potent inhibitors of the tankyrases